Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Dec;36(12):2835–2838. doi: 10.1128/aac.36.12.2835

In vitro activities of Ro 40-6890 against 164 predominantly intestinal members of the families Enterobacteriaceae and Vibrionaceae.

P Hohl 1, J Zollinger-Iten 1, A von Graevenitz 1
PMCID: PMC245554  PMID: 1482154

Abstract

The in vitro activities of Ro 40-6890, the active metabolite of a novel orally absorbable cephalosporin ester, Ro 41-3399, against 164 nonfastidious aerobic gram-negative rods of predominantly intestinal origin from patients with diarrhea were evaluated by the agar dilution method recommended by the National Committee for Clinical Laboratory Standards. Ro 40-6890 was inhibitory (MIC for 90% of isolates [MIC90], 0.12 micrograms/ml) against the majority of intestinal members of the families Enterobacteriaceae and Vibrionaceae (Vibrio spp., Aeromonas spp., and Plesiomonas shigelloides). The potency of Ro 40-6890 was very similar to that of cefotaxime (MIC90, 0.12 micrograms/ml) and distinctly higher than those of cefadroxil (MIC90, > or = 128 micrograms/ml) and amoxicillin-clavulanic acid (MIC90, 32 micrograms/ml-2 micrograms/ml).

Full text

PDF
2835

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angehrn P., Hohl P., Hubschwerlen C., Page M., Then R. Antibacterial properties of Ro 40-6890, a broad-spectrum cephalosporin, and its novel orally absorbable ester, Ro 41-3399. Antimicrob Agents Chemother. 1992 Dec;36(12):2825–2834. doi: 10.1128/aac.36.12.2825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gaudreau C. L., Lariviere L. A., Lauzer J. C., Turgeon F. F. Effect of clavulanic acid on susceptibility of Campylobacter jejuni and Campylobacter coli to eight beta-lactam antibiotics. Antimicrob Agents Chemother. 1987 Jun;31(6):940–942. doi: 10.1128/aac.31.6.940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hubschwerlen C., Charnas R., Angehrn P., Furlenmeier A., Graser T., Montavon M. Orally active 2-(alkyloxycarbonyl)-2-alkylideneethyl esters of cephalosporins. J Antibiot (Tokyo) 1992 Aug;45(8):1358–1364. doi: 10.7164/antibiotics.45.1358. [DOI] [PubMed] [Google Scholar]
  4. Lemaitre B. C., Mazigh D. A., Scavizzi M. R. Failure of beta-lactam antibiotics and marked efficacy of fluoroquinolones in treatment of murine Yersinia pseudotuberculosis infection. Antimicrob Agents Chemother. 1991 Sep;35(9):1785–1790. doi: 10.1128/aac.35.9.1785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. San Joaquin V. H., Scribner R. K., Pickett D. A., Welch D. F. Antimicrobial susceptibility of Aeromonas species isolated from patients with diarrhea. Antimicrob Agents Chemother. 1986 Nov;30(5):794–795. doi: 10.1128/aac.30.5.794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Soriano F., Ponte C., Fernández-Roblas R. Antibiotics in yersiniosis. J Antimicrob Chemother. 1988 Feb;21(2):261–262. doi: 10.1093/jac/21.2.261. [DOI] [PubMed] [Google Scholar]
  7. Van der Auwera P., Scorneaux B. In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam. Antimicrob Agents Chemother. 1985 Jul;28(1):37–40. doi: 10.1128/aac.28.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Wauters G., Kandolo K., Janssens M. Revised biogrouping scheme of Yersinia enterocolitica. Contrib Microbiol Immunol. 1987;9:14–21. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES